Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-20-021215
Filing Date
2020-11-02
Accepted
2020-11-02 07:00:35
Documents
4
Period of Report
2020-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp139888_6k.htm 6-K 12558
2 EXHIBIT 99.1 dp139888_ex9901.htm EX-99.1 13599
3 GRAPHIC image_004.gif GRAPHIC 1351
4 GRAPHIC image_005.gif GRAPHIC 1351
  Complete submission text file 0000950103-20-021215.txt   31106
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 201278942
SIC: 2836 Biological Products, (No Diagnostic Substances)